An Infant With Recalcitrant Diaper Dermatitis

Abstract

Get full access to this article

View all access options for this article.

References

Krooks

Minkov

Weatherall

AG.

Langerhans cell histiocytosis in children: history, classification, pathobiology, clinical manifestations and prognosis. J Am Acad Dermatol. 2018;78:1035-1044.

Jezierska

Stefanowicz

Romanowicz

Kosiak

Lange

Langerhans cell histiocytosis in children—a disease with many faces. Recent advances in pathogenesis, diagnostic examinations and treatment. Postepy Dermatol Alergol. 2018;35:6-17.

Gadner

Grois

Arico

et al . A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis. J Pediatr. 2001;138:728-734.

Morren

Vanden Broecke

Vangeebergen

et al . Diverse cutaneous presentations of Langerhans cell histiocytosis in children: a retrospective cohort study. Pediatr Blood Cancer. 2016;63:486-492.

Lau

Chu

Weiss

LM.

Immunohistochemical expression of langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615-619.

Valladeau

Ravel

Dezutter-Dambuyant

et al . Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 2000;12:71-81.

Allen

Peters

et al . Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184:4557-4567.

Willman

CL.

Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance. Br J Cancer Suppl. 1994;23:S29-S33.

Badalian-Very

Vergilio

Degar

et al . Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:1919-1923.

10.

Berres

Lim

Peters

et al . BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211:669-683.

11.

Simko

Garmezy

Abhyankar

et al . Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr. 2014;165:990-996.

12.

Krooks

Minkov

Weatherall

AG.

Langerhans cell histiocytosis in children: diagnosis, differential diagnosis, treatment, sequelae and standardized follow-up. J Am Acad Dermatol. 2018;78:1047-1056.

13.

Gadner

Minkov

Grois

et al . Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121:5006-5014.

14.

Abla

Weitzman

Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition. Hematology Am Soc Hematol Educ Program. 2015;2015:565-570.

15.

Lau

Krafchik

Trebo

Weitzman

Cutaneous Langerhans cell histiocytosis in children under one year. Pediatr Blood Cancer. 2006;46:66-71.